 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Updated: December 20, 2024
This database of Alerts is updated periodically, usually once a month. The most recent Alert issued is # 310 while the most recent one archived here is # 309. Recently issued Alerts will make it here, eventually. If you would like to receive the Alerts in the form of emails as they are issued, you may register at our Alert Subscription page.
NOTICE: This database contains the text of messages originally sent as emails to subscribers of Topics Alert, a free service of CLL Topics Inc. The content of this database is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
To read any of the Alerts listed below, simply click on the title of your choice anywhere in the list.
You may also enter the Alert number in the box below and click "Display".
Please restrict your entry to a number actually listed here, in the range between 1 and 309.
# Date Title
309 Dec 18, 2024 Acupuncture
308 Dec 06, 2024 Toxoplasmosis (Cat Lovers - Beware!)
307 Dec 02, 2024 Take Care of your Ticker
306 Nov 20, 2024 Pneumonia - the Alpha and Omega for CLL Patients
305 Nov 07, 2024 Familial CLL
304 Nov 03, 2024 ITP: It Really Helps to Get Rid of the Bugs in Your Stomach
303 Nov 01, 2024 MGUS: Not So Benign After All
302 Oct 28, 2024 Fighting Two Wars at the Same Time
301 Oct 27, 2024 Campath in the News
300 Oct 09, 2024 Double Trouble : More is Not Better When it Comes to 13q Deletions
299 Oct 09, 2024 A New "Superbug" to Torment Us
298 Sep 29, 2024 A Good Day to Talk about Depression
297 Sep 27, 2024 Two New Clinical Trials With HuMax-CD20
296 Sep 24, 2024 Dirty Lab Coats: Doctors Who Compromise Patients' Health
295 Sep 22, 2024 Tanning Beds? Not Even if You Are a Republican!
294 Sep 21, 2024 A New Anti-CD20 Monoclonal in Clinical Trials
293 Sep 13, 2024 Rituxan in the news
292 Sep 06, 2024 Revlimid (aka lenalidomide) in the news
291 Aug 04, 2024 The physician - patient relationship
290 Jul 31, 2024 Humax-CD20 clinical trial results
289 Jul 28, 2024 NK Cell Therapy: Better Than Transplants?
288 Jul 25, 2024 At last! Some one did the Rituxan experiment that needed to be done
287 Jul 09, 2024 Warning: Cipro, Levaquin may cause serious tendon damage
286 Jul 04, 2024 Do Not Go Gentle Into That Good Night
285 Apr 25, 2024 Mantle Cell Lymphoma and Lyme disease
283 Mar 31, 2024 Low hemoglobin and platelets: the WHY is important
281 Mar 08, 2024 Rituxan + Fenretinide Clinical Trial Update
280 Mar 04, 2024 Does prior Rituxan therapy take away "chemo naive" status?
279 Mar 02, 2024 Are CLL patients living longer?
277 Feb 25, 2024 A Bold New Journey Starts
276 Feb 19, 2024 CLL - Work in Progress
275 Feb 12, 2024 The flu bug is particularly nasty this year
274 Feb 10, 2024 Single agent fludarabine: Don't do it
273 Jan 18, 2024 Mini-allo MUD transplants at the NCI
272 Jan 16, 2024 A Great Man Has Died
271 Jan 12, 2024 Hearing Patients' Voices
270 Jan 05, 2024 EPO Drugs - Not to Be Overused
269 Dec 23, 2024 Keep Your Money Where It Is Most Needed
268 Dec 20, 2024 CT Scans: Are They Necessary to Evaluate Response to Therapy?
267 Dec 20, 2024 Genitope's MyVax Disappoints
266 Dec 13, 2024 Treanda: A Facelift for Bendamustine
265 Dec 07, 2024 Flu Season: Prevention, Prevention and More Prevention …
264 Dec 06, 2024 ITP: Immune Thrombocytopenia
262 Nov 27, 2024 Green Tea - Phase I Trial Results at Mayo Clinic
261 Nov 25, 2024 Secondary Cancers in CLL
260 Nov 17, 2024 Tell It Like It Is, Please
259 Nov 16, 2024 HuMax-CD20 Clinical Trial Results
258 Nov 12, 2024 Genitope CLL Vaccine Trial Update
257 Oct 16, 2024 Ground Rules
256 Oct 14, 2024 Grim News for Refractory Patients
255 Oct 08, 2024 Dithering Is Human
254 Oct 07, 2024 Jab & Dab: Clinical Trial Launched
253 Sep 29, 2024 Quality of Life with CLL
252 Sep 24, 2024 Campath as Frontline Therapy
251 Sep 19, 2024 The Best and Worst of American Medicine
250 Sep 10, 2024 Making Sensible Decisions About Stem Cell Transplants
248 Sep 01, 2024 Call to Action
247 Aug 29, 2024 FISHing in Murky Waters
246 Aug 17, 2024 What You Don't Know Can Hurt You
245 Aug 15, 2024 Prophylaxis: Do It Right — Take the Necessary Precautions Ahead of Time
244 Aug 12, 2024 With a Little Help from a Million or So of Your Friends
243 Aug 10, 2024 Cord Blood Transplants: The State of the Art
242 Aug 08, 2024 Gene Therapies
241 Jul 14, 2024 Lyme Disease and CLL
240 Jul 05, 2024 Autoimmune Complications
239 Jul 04, 2024 Catch 22: The Transplant Minefield
238 Jun 12, 2024 Harvey's Battle Plans
237 Jun 08, 2024 Got Protection? Immunoglobulins
236 Jun 08, 2024 Secondary Cancers in CLL & What You Can Do to Protect Yourself
235 May 27, 2024 “Vaccine Therapy” Clinical Trial at Baylor
234 May 26, 2024 FUO: Fevers of Unknown Origin
233 May 16, 2024 Bexxar: An Introduction to Radioimmunotherapy
232 May 11, 2024 Rituxan: Delayed Onset Neutropenia
231 May 07, 2024 Protecting the Borders
230 May 04, 2024 Mini-allo Transplants Just Got Safer
229 Apr 29, 2024 Tumor Load, Lactic Acid, Cramps and Infections
228 Apr 22, 2024 Refractory AIHA: What Comes After Steroids and Rituxan?
227 Apr 12, 2024 CAT-8015 Clinical Trial
226 Apr 05, 2024 How Old Is “Old”?
225 Apr 01, 2024 Treating Autoimmune Disease: ITP and AIHA in CLL
224 Mar 28, 2024 Conflict of Interest Can Kill
223 Mar 25, 2024 AIHA and FCR Therapy
222 Mar 09, 2024 FDA Gets Serious about EPO Warning
221 Mar 06, 2024 This Year's Flu
220 Mar 06, 2024 “Lumi” — The New Babe in Town
219 Mar 04, 2024 Using Revlimid Outside Clinical Trials
218 Jan 30, 2024 Revlimid Phase II Results at ASH 2024
217 Jan 27, 2024 Therapy Induced Pulmonary Toxicity
216 Jan 25, 2024 Two Flu Shots Better than One?
215 Jan 21, 2024 Curry and Spice and All Things Nice (?!)
214 Jan 20, 2024 Steroid Therapy and Potential Diseases of the Eye
213 Jan 08, 2024 Rituxan + Fenretinide: A Brand New Clinical Trial Sponsored by CLL Topics
212 Jan 06, 2024 More on Stem Cell Transplants — Almost Free
211 Jan 03, 2024 Sibling Donor Stem Cell Transplants - Almost Free
207 Nov 30, 2024 Toxicity and "Chemo Brain"
206 Nov 28, 2024 Credible Information on Vitamin D3 — The Vitamin D Council
205 Nov 27, 2024 Women Donors for Stem Cell Transplants
204 Nov 24, 2024 Vitamin D3 and Infections
203 Nov 18, 2024 Easy Does It — Questioning the Gold Standard
202 Nov 17, 2024 Bronchitis: Don't Reach for the Antibiotics
201 Nov 16, 2024 Epoetin: Money Makes the World Go Around
200 Nov 16, 2024 Tregs Revealed: Regulators and Killers
199 Nov 13, 2024 Familial CLL: New Developments
198 Nov 08, 2024 Respiratory Infections
196 Sep 19, 2024 Management of Early Stage, Newly Diagnosed Patients
193 Sep 02, 2024 Illusions: I Have CLL but I Never Get Sick
192 Sep 02, 2024 Infections: Who Is Most at Risk?
191 Aug 31, 2024 Steroid-Campath Combinations: A Sledgehammer To Be Used Wisely
190 Aug 30, 2024 News Report: Drug companies "manipulating trials"
189 Aug 26, 2024 Rituxan: the Shaving Reaction
188 Aug 24, 2024 CLL: Diagnosis and Treatment — Overview Article
187 Aug 21, 2024 MRSA: A Deadly Super Bug
186 Aug 16, 2024 Vitamin D3 Debate Continues
184 Aug 12, 2024 HuMax-CD20: Belt, Suspenders — and Cummerbund
183 Aug 12, 2024 Usefulness of Online Medical Information
182 Aug 02, 2024 CLL Topics in the News
181 Aug 01, 2024 Genitope Vaccine Trial: Developments
180 Jul 31, 2024 CLL and Risk of Lung Cancer
179 Jul 28, 2024 A Bullseye on Rituxan
178 Jul 26, 2024 Bird Flu (H5N1): Some Hopeful News
177 Jul 22, 2024 Doxorubicin: the Gift that Keeps on Giving
176 Jul 22, 2024 Pushing Revlimid
175 Jul 21, 2024 Simvastatin, EBV-Driven Lymphomas, Patents
174 Jul 20, 2024 David vs. Goliath - Comparing HuMax-CD20 with Rituxan
173 Jul 14, 2024 Filtering Out EBV Noise
172 Jul 08, 2024 Mononucleosis and CLL: a Straw Poll
171 Jul 05, 2024 EBV: The Enemy Within
170 Jun 20, 2024 Quality of Life with CLL
169 Jun 18, 2024 CLL and Skin Cancers: How to "Sell" Your Doctors
168 Jun 16, 2024 Summer Is Here — and So Are Skin Cancer Worries
167 Jun 10, 2024 Infections Kill CLL Patients
166 Jun 07, 2024 Safety Concerns: Epogen, Procrit, Aranesp
165 Jun 05, 2024 How Did We Get Here From There?
164 May 26, 2024 Harvey is Back! An Update on Genmab's HuMax-CD20
163 May 26, 2024 Project Alpha Update
162 May 26, 2024 Transparency in Clinical Trials: Your Life Depends on It
161 May 18, 2024 Money Makes the World Go Round
160 May 14, 2024 Jab & Dab
159 Apr 10, 2024 An Update on Harvey
158 Apr 04, 2024 Stem Cell Transplants: Are You a Good Candidate?
157 Mar 22, 2024 Honor Is Due
156 Mar 22, 2024 CLL, the "Chronic Condition"?
155 Mar 19, 2024 F+C vs F Comparison
154 Mar 15, 2024 Thalidomide in Blood Cancers: Disappointing Results
153 Mar 05, 2024 A Vaccine Trial for CLL Patients
152 Feb 26, 2024 Forest Bump
151 Feb 16, 2024 Aranesp Safety Warning
150 Jan 31, 2024 Rituxan Adverse Effects
149 Feb 09, 2024 CLL Therapy: Winning the Battle but Losing the War?
148 Feb 07, 2024 Green Tea Extracts (EGCG) and Weight Loss
147 Feb 06, 2024 Latest on Green Tea Extracts (EGCG)
146 Jan 23, 2024 Lymphocyte Doubling Time
145 Jan 18, 2024 Comparing Apples and Kumquats
144 Jan 12, 2024 FCR Lite — The Goldilocks Dilemma
143 Jan 06, 2024 RF Risks and Benefits
142 Jan 03, 2024 Early Results from GenMab's HuMax Clinical Trial
141 Dec 14, 2024 Omega-3 Fats in Fish Oil Combat Pulmonary Inflammation
140 Dec 09, 2024 EGCG: Early Clinical Results in CLL Patients
139 Dec 09, 2024 Suspension of 17-AAG Clinical Trial
137 Nov 17, 2024 Avian Flu and CLL
136 Nov 11, 2024 FISH, "Normal" Karyotype, and Clonal Evolution
135 Nov 09, 2024 MCL - a Wolf in CLL Clothing
134 Nov 02, 2024 Three New CLL Clinical Trials - All Targeting Bcl-2
133 Oct 19, 2024 Familial CLL: a Reminder
132 Oct 11, 2024 F versus FC
131 Sep 29, 2024 Mayo Website Article on Bird Flu
129 Sep 28, 2024 Bird Flu in Humans
128 Sep 24, 2024 The Big Business of Clinical Trials
127 Sep 22, 2024 Things that Go Bump in the Night: The Flu Season Is Upon Us
126 Sep 16, 2024 New Improved CD20 Monoclonal from Genmab
125 Sep 08, 2024 Skin Cancer Worries: Useful Contact Information
124 Sep 07, 2024 Novel Immunotherapy Trial at the Hutch
123 Aug 22, 2024 Project Alpha Begins Patient Recruitment
122 Aug 19, 2024 The Brit. Version of FCR+M
121 Aug 17, 2024 Death by Conventional Wisdom
120 Aug 12, 2024 Dr. Faderl's Response
119 Aug 11, 2024 A Turbocharged Clinical Trial: FCR+M
118 Aug 10, 2024 Balancing Risks and Rewards: FCR+M Clinical Trial
117 Aug 09, 2024 FRC, Kicked Up Another Notch!
116 Aug 06, 2024 What to Avoid in Stem Cell Transplants
115 Aug 04, 2024 A Statin a Day
114 Aug 01, 2024 Risk Adapted Strategies
113 Aug 01, 2024 Genmab's HuMax-CD20 Clinical Trial
112 Jul 29, 2024 GVHD in Allo Stem Cell Transplants
111 Jul 27, 2024 Medscape Review: Epidemic of Skin Cancers
110 Jul 26, 2024 Nice to See the Good Guys Win
109 Jul 19, 2024 The Only Real Cure Out There, for Now
108 Jul 19, 2024 Fludarabine Therapy Increases Risk of Skin Cancer
107 Jul 17, 2024 An Interesting Vaccine Trial for CLL Patients
106 Jul 16, 2024 A New Lease on Life for "Bucket C" Patients
105 Jul 14, 2024 Special Care for Your Heart
104 Jun 24, 2024 17-AAG: A Brand New Clinical Trial
103 Jun 22, 2024 G-CSF or GM-CSF? Which Is the Safer Choice?
102 Jun 21, 2024 Rituxan plus Leukine (GM-CSF) Has Benefit in NHL
101 Jun 21, 2024 IgVH Test, Quest, Ohio State
100 Jun 20, 2024 Telling It Like It Is
99 Jun 09, 2024 Interview with Honokiol Researchers
98 May 08, 2024 Don't Waste Your Money
97 May 26, 2024 Fludarabine: Risk of Richter’s Transformation
96 May 23, 2024 Revlimid: A Breakthrough?!?
95 May 21, 2024 A Morality Tale of Two Friends
94 May 16, 2024 Buddy Can You Spare a Little Blood to Get this Research Going?
92 May 08, 2024 Honokiol: Miracle Herb or Feel Happy Pill?
91 Apr 21, 2024 Benefits of IVIg: Worth Examining
90 Apr 21, 2024 Aldara: a Promising New Drug for Actinic Keratosis
88 Apr 20, 2024 More on Prognostic Test Packages - Take Care of the Details
87 Apr 03, 2024 Affordable Prognostic Testing - Now Available at Last!
86 Mar 18, 2024 CLL Global Research Foundation
85 Mar 16, 2024 The Dangers of Vitamin E Supplements
84 Mar 13, 2024 Rituxan plus Short Duration Campath
83 Mar 06, 2024 Good News for the Tough Cases - Campath to the Rescue
82 Feb 26, 2024 Who Is Driving the Bus?
81 Feb 25, 2024 The Dawn of a New Era
80 Feb 23, 2024 Anemia Can Be a Silent Killer
79 Feb 19, 2024 Project Alpha Fundraising Goal Reached
78 Feb 17, 2024 Inquiring Minds: This Might Be Good for a Chuckle or Two
77 Feb 16, 2024 The Difference Is Friendliness
76 Feb 10, 2024 Progress on Prognostics
75 Feb 04, 2024 Genitope: Vaccine Approach to B-Cell Cancers
74 Jan 31, 2024 More on Mouth Sores: An Expert Weighs In
73 Jan 30, 2024 Oral Sores Can Get Pretty Ugly
72 Jan 28, 2024 Dr. Hamblin Speaks Out
71 Jan 23, 2024 A Fishy Tale
70 Jan 21, 2024 Aranesp Warning – The Dark Side of Epo
69 Jan 12, 2024 A Real Pain in the Mouth
68 Dec 23, 2024 "Harvey" Is Doing Well
67 Dec 23, 2024 Remicade Warning
66 Dec 20, 2024 An Early Christmas Present from Blood
65 Dec 20, 2024 Gifts From the Heart
64 Dec 18, 2024 Matching Made Simple
63 Dec 17, 2024 Vioxx Gone - Now Celebrex Is Out Too
62 Dec 12, 2024 ASH 2024 Highlights
61 Dec 11, 2024 EGCG Candy - Just in Time for the Holiday Season
60 Dec 08, 2024 Squamous Cell Carcinoma
59 Nov 27, 2024 Genes Sleeping on the Job
57 Nov 16, 2024 R plus HDPM
56 Nov 11, 2024 How Much EGCG Should You Take?
55 Nov 09, 2024 Shopping for the Right Therapy
54 Oct 26, 2024 CDC Advisory on Anti-virals in Response to Flu Vaccine Shortage
53 Oct 25, 2024 Cancer Drugs, Wheelchairs on Medicare's Cutback List
51 Oct 15, 2024 New Rituxan Combination in the News
49 Oct 11, 2024 Rituxan Warning
48 Oct 09, 2024 Vioxx Is Out but How About Celebrex?
47 Oct 05, 2024 Those Pesky Aches and Pains
46 Oct 04, 2024 A Derivative of Celebrex as Potential CLL Drug
45 Oct 01, 2024 Vioxx Warning
44 Sep 29, 2024 Exciting New Drugs on the CLL Horizon
42 Sep 15, 2024 CLL and Basal Cell Carcinoma
41 Sep 14, 2024 ZAP-70 and IgVH Gene Mutation Status as Prognostic Indicators
40 Sep 02, 2024 "Teavigo": Roche's High EGCG Content Product
39 Aug 24, 2024 Mayo Best Practices
38 Aug 15, 2024 AIHA: Autoimmune Hemolytic Anemia
34 Jul 30, 2024 Clinical Trial Results: Rituxan + Campath
32 Jul 15, 2024 New York Times editorial on July 14, "Choosing Death"
31 Jul 14, 2024 Familial CLL: An Expert Opinion
30 Jul 06, 2024 Adding Neupogen to Rituxan Therapy
29 Jun 30, 2024 FluCam-106
28 Jun 25, 2024 Project Alpha Milestones
27 Jun 24, 2024 The Dangers of Overmedication
26 Jun 15, 2024 "Coral Calcium"
25 Jun 15, 2024 The Flip Side of Sun Avoidance – Too Little Vitamin D3
24 Jun 06, 2024 Flavopiridol - a Drug that May Save Lives
22 May 13, 2024 Fludarabine Monotherapy No Longer the Gold Standard
21 May 12, 2024 Corticosteroid Therapy and Increased Risk of Skin Cancer
18 May 06, 2024 More on "Harvey’s Chocolates"
17 May 04, 2024 Harvey’s Chocolates
16 Apr 30, 2024 Bone Loss after Stem Cell Transplants
15 Apr 20, 2024 Familial CLL
14 Apr 18, 2024 Hitting a Home Run with Campath Consolidation?
13 Mar 15, 2024 Results of Phase - 2 Ontak in Relapsed CLL Patients
12 Apr 13, 2024 LMB-2 in Phase - II Trial Sponsored by NCI
11 Apr 13, 2024 Combination of Rituxan plus Campath in Relapsed CLL Patients
10 Apr 08, 2024 Is Rituxan More Dangerous Than Fludarabine?
9 Mar 31, 2024 Comparing Clinical Trials
8 Mar 28, 2024 Stem Cell Transplants in CLL Patients: Dana Farber Statistics
7 Mar 26, 2024 CLL Greatly Increases Your Risk of Skin Cancer
6 Mar 24, 2024 Fludarabine as Front-line Therapy
5 Mar 22, 2024 Sinus and Pulmonary Problems in CLL
4 Mar 21, 2024 ZAP-70 Testing: Where to Go, How Much It Costs
3 Mar 20, 2024 Two Popular Anemia Drugs Under FDA Scrutiny
2 Mar 19, 2024 Deletion of 6q21 and Prognostic Risk
1 Mar 18, 2024 What You Need to Know – Mayo "Best Practices"
 Enter Keywords: |
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
